Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, vehicle-controlled, double-blind parallel group study to
evaluate the efficacy and safety of CD 2027 Oily Spray applied twice daily for 8 weeks in
subjects with plaque-type psoriasis.